Showing results (81-90 of 127) with videos related to
Sort By:
Pageof 13
Cancer Chemotherapy and Pharmacology|July 15, 2021
Prospective clinical trial testing COXEN-based gene expression models of chemosensitivity in dogs with spontaneous osteosarcomaDaniel L Gustafson, Keagan P Collins, Jared S Fowles, et al.American Journal of Veterinary Research|November 27, 2012
Effects of intratumoral administration of a hyaluronan-cisplatin nanoconjugate to five dogs with soft tissue sarcomasRachel O Venable, Deanna R Worley, Daniel L Gustafson, et al.The Journal of Pharmacology and Experimental Therapeutics|January 16, 2013
Neuroprotective efficacy and pharmacokinetic behavior of novel anti-inflammatory para-phenyl substituted diindolylmethanes in a mouse model of Parkinson's diseaseBriana R De Miranda, James A Miller, Ryan J Hansen, et al.Journal of Feline Medicine and Surgery|October 30, 2019
Pilot study of side effects and serum and urine concentrations of amoxicillin-clavulanic acid in azotemic and non-azotemic catsKellyi K Benson, Jessica M Quimby, Kristy L Dowers, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
Investigation of two dosing schedules of vandetanib (ZD6474), an inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling, in combination with irinotecan in a human colon cancer xenograft modelTeresa Troiani, Natalie J Serkova, Daniel L Gustafson, et al.Investigational New Drugs|November 2, 2006
A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patientsThomas W Flaig, Daniel L Gustafson, Lih-Jen Su, et al.BMC Veterinary Research|June 3, 2014
Development of an in vitro model of acquired resistance to toceranib phosphate (Palladia®) in canine mast cell tumorCharles H C Halsey, Daniel L Gustafson, Barbara J Rose, et al.Molecular Cancer Therapeutics|December 17, 2008
A phase I study of gefitinib, capecitabine, and celecoxib in patients with advanced solid tumorsElaine T Lam, Cindy L O'Bryant, Michele Basche, et al.Plos One|March 23, 2013
Utilization of quantitative in vivo pharmacology approaches to assess combination effects of everolimus and irinotecan in mouse xenograft models of colorectal cancerErica L Bradshaw-Pierce, Todd M Pitts, Gillian Kulikowski, et al.Veterinary Ophthalmology|April 28, 2011
Evaluation of the ocular penetration of topical alpha-luminol (Galavit®/GVT®)Enry G da Silva, Juliet R Gionfriddo, Susan F Hudachek, et al.Pageof 13